Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults

Addictive Behaviors

Volumn 37, Issue 1, 2012, Pages 78-84

  Tsai, James ^a   Ford, Earl S ^a   Li, Chaoyang ^a   Zhao, Guixiang ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Alanine aminotransferase (ALT); Alcohol consumption; Aminotransferase; Aspartate aminotransferase (AST); Former drinkers; Gamma glutamyl transferase (GGT)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RISK ASSESSMENT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ALCOHOLISM; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 80054737387     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2011.09.002     Document Type: Article

References (54)

1. Alatalo P., Koivisto H., Puukka K., Hietala J., Anttila P., Bloigu R., et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol and Alcoholism 2009, 44:199-203.
2. Anton R.F. Editorial commentary: Alcohol biomarker papers. Alcoholism, Clinical and Experimental Research 2010, 34:939-945.
3. APHA Alcohol screening and brief intervention: A guide for public health practitioners 2008, Washington DC: National Highway Traffic Safety Administration, U.S. Department of Transportation. American Public Health Association (APHA) and Education Development Center, Inc.
4. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology 2003, 3:21.
5. Breslow R.A., Graubard B.I. Prospective study of alcohol consumption in the United States: quantity, frequency, and cause-specific mortality. Alcoholism, Clinical and Experimental Research 2008, 32:513-521.
6. CDC Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR 2007, 58:1-27.
7. CDC Cigarette smoking among adults and trends in smoking cessation-United States, 2008. JAMA: The Journal of the American Medical Association 2009, 302:2651-2654.
8. CDC The guide to community preventive services. Centers for Disease Control and Prevention. Atlanta, Georgia Url:. http://www.thecommunityguide.org/pa/index.html.
9. CDC National Health and Nutrition Examination Survey. Centers for Disease Control and Prevention (CDC) Atlanta, Georgia. Url:. http://www.cdc.gov/nchs/nhanes.htm.
10. CDC Age standardization and population counts Atlanta, Georgia. Accessed June 2011. Url:, U.S. Department of Health and Human Services, Atlanta, Georgia. http://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/AgeStandardization/age_standardization_intro.htm.
11. CDC Alcohol-Related Disease Impact (ARDI) system Atlanta, Georgia. Accessed June 2011. Url:, U.S. Department of Health and Human Services, Atlanta, Georgia. https://apps.nccd.cdc.gov/ardi/Homepage.aspx.
12. CDC Think before you drink: excessive alcohol use can lead to health problems such as liver disease, unintentional injuries, and fetal alcohol spectrum disorders (FASDs) Atlanta, Georgia. Accessed June 2011. Url:, U.S. Department of Health and Human Services, Atlanta, Georgia. http://www.cdc.gov/Features/ds5Drinks1Day/.
13. Conigrave K.M., Davies P., Haber P., Whitfield J.B. Traditional markers of excessive alcohol use. Addiction 2003, 98(Suppl 2):31-43.
14. Giannini E.G., Testa R., Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2005, 172:367-379.
15. Giboney P.T. Mildly elevated liver transaminase levels in the asymptomatic patient. American Family Physician 2005, 71:1105-1110.
16. Gramenzi A., Caputo F., Biselli M., Kuria F., Loggi E., Andreone P., et al. Review article: alcoholic liver disease-pathophysiological aspects and risk factors. Alimentary Pharmacology & Therapeutics 2006, 24:1151-1161.
17. Hart C.L., Morrison D.S., Batty G.D., Mitchell R.J., Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010, 340:c1240.
18. Hughes S.C., Chambers C.D., Kassem N., Wahlgren D.R., Larson S., Riley E.P., et al. Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas. Maternal and Child Health Journal 2009, 13:857-864.
19. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
20. Kim H.C., Nam C.M., Jee S.H., Han K.H., Oh D.K., Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004, 328:983.
21. Korn E., Graubard B. Analysis of health surveys 1999, John Wiley and Sons, Inc., New York.
22. Lee I.M., Djousse L., Sesso H.D., Wang L., Buring J.E. Physical activity and weight gain prevention. JAMA: the journal of the American Medical Association 2010, 303:1173-1179.
23. Lee T.H., Kim W.R., Benson J.T., Therneau T.M., Melton L.J. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008, 47:880-887.
24. Mason J.E., Starke R.D., Van Kirk J.E. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Preventive Cardiology 2010, 13:36-41.
25. NACB Laboratory medicine practice guidelines: laboratory guidelines for screening, diagnosis and monitoring of hepatic injury 2000, The National Academy of Clinical Biochemistry (NACB), Washington, DC.
26. Nelson D.E., Powell-Griner E., Town M., Kovar M.G. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. American Journal of Public Health 2003, 93:1335-1341.
27. NIAAA Alcohol alert: Alcohol metabolism 1997, No. 35. National Institute on Alcohol Abuse and Alcoholism (NIAAA), Rockville, MD.
28. NIAAA Alcohol alert: Are women more vulnerable to alcohol's effects? 1999, National Institute on Alcohol Abuse and Alcoholism (NIAAA). No. 46, Rockville, MD.
29. NIAAA National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician's guide 2005, NIH Pub No. 05-3769. Bethesda, MD.
30. Nijem K., Kristensen P., Al-Khatib A., Bjertness E. Application of different statistical methods to estimate relative risk for self-reported health complaints among shoe factory workers exposed to organic solvents and plastic compounds. Norsk Epidemiologi 2005, 15:111-116.
31. Noar S.M., Benac C.N., Harris M.S. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychological Bulletin 2007, 133:673-693.
32. Nyblom H., Berggren U., Balldin J., Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol and Alcoholism 2004, 39:336-339.
33. O'Shea R.S., Dasarathy S., McCullough A.J. Alcoholic liver disease. American Journal of Gastroenterology 2010, 105:14-32.
34. Peterson K. Biomarkers for alcohol use and abuse: A summary. Alcohol Research & Health 2004, 28:30-37.
35. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. The New England Journal of Medicine 2000, 342:1266-1271.
36. Rehm J. Measuring quantity, frequency, and volume of drinking. Alcoholism, Clinical and Experimental Research 1998, 22:4S-14S.
37. Rehm J., Ashley M.J., Room R., Single E., Bondy S., Ferrence R., et al. On the emerging paradigm of drinking patterns and their social and health consequences. Addiction 1996, 91:1615-1621.
38. Rehm J., Room R., Graham K., Monteiro M., Gmel G., Sempos C.T. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 2003, 98:1209-1228.
39. Rehm J., Taylor B., Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review 2006, 25:503-513.
40. Ruhl C.E., Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009, 136:477-485.
41. Ruhl C.E., Everhart J.E. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010, 138:1346-1356. 1356 e1341-1343.
42. St George A., Bauman A., Johnston A., Farrell G., Chey T., George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. Journal of Gastroenterology and Hepatology 2009, 24:399-407.
43. St George A., Bauman A., Johnston A., Farrell G., Chey T., George J. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009, 50:68-76.
44. Stockwell T., Donath S., Cooper-Stanbury M., Chikritzhs T., Catalano P., Mateo C. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 2004, 99:1024-1033.
45. Stranges S., Freudenheim J.L., Muti P., Farinaro E., Russell M., Nochajski T.H., et al. Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcoholism, Clinical and Experimental Research 2004, 28:949-956.
46. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer-A narrative review. Clinical Chemistry and Laboratory Medicine 2010, 48:147-157.
47. Tsai J., Floyd R.L., O' Connor M.J. Paradigms for alcohol use and co-occurring behavioral health risk factors among women of childbearing age. Binge drinking research progress 2008, 87-100. Nova Science Publishers, Inc, Hauppauge, NY. K.I. DiGuarde (Ed.).
48. Tsai J., Ford E.S., Li C., Pearson W.S., Zhao G. Binge drinking and suboptimal self-rated health among adult drinkers. Alcoholism, Clinical and Experimental Research 2010, 34:1465-1471.
49. Tsai J., Ford E.S., Li C., Zhao G., Pearson W.S., Balluz L.S. Multiple healthy behaviors and optimal self-rated health: Findings from the 2007 behavioral risk factor surveillance system survey. Preventive Medicine 2010, 51:268-274.
50. Tsai J., Ford E.S., Zhao G., Li C., Greenlund K.J., Croft J.B. Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults. Journal of Behavioral Medicine 2011, 10.1007/s10865-011-9353-5.
51. Turgut O., Tandogan I., Gurlek A. Association of [gamma]-glutamyltransferase with cardiovascular risk: A prognostic outlook. Archives of Medical Research 2009, 40:318-320.
52. Wannamethee S.G., Shaper A.G. Cigarette smoking and serum liver enzymes: the role of alcohol and inflammation. Annals of Clinical Biochemistry 2010, 47:321-326.
53. Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Research & Health 2006, 29:245-254.
54. Zakhari S., Li T.K. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology 2007, 46:2032-2039.